Recent studies have also indicated that FLCN suppresses transcription factor E3 and transforming growth factor (TGF)-β, which may additionally lead to the development of renal tumors in BHD patients (22, 23), highlighting the significance of these pathways in BHD-related tumorigenesis. The gene discussed is FLCN; the disease is Birt-Hogg-Dube syndrome.